Pharmaceutical company Pfizer has announced that it will end its research and development programs for Alzheimer’s and Parkinson’s treatments and “re-allocate funding to those areas where...
High ratings fuel recognition for 1,600 senior living operators
By
John O'Connor
Dec 14, 2017
SeniorAdvisor.com announced that more than 1,600 senior living communities have been recognized as among the best in the business.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Americans not prepared for Alzheimer’s: poll
By
Lois A. Bowers
Nov 07, 2017
More than half of respondents to a recent poll about Alzheimer’s disease greatly underestimated the costs of long-term care.
Take two Bunny Hops and call me in the morning
By
John O'Connor
Nov 06, 2017
As drug companies invest millions of dollars to find Alzheimer’s treatments, one research team is dancing to a different drummer. Actually, dancing to a drummer could be part of its investigation.
Learn about Montessori in memory care and earn a CE credit Oct. 4
Sep 12, 2017
Participants in an Oct. 4 McKnight’s Senior Living webinar will earn one CE credit while learning about emerging trends in Alzheimer’s disease and how one senior living operator is using Montessori...
Stand-alone memory care properties challenge LTC Properties in second quarter
By
Lois A. Bowers
Aug 10, 2017
LTC Properties has issued a default notice to the primary operator of stand-alone memory care communities in its portfolio and is planning to transition two properties away from the other operator of stand-alone...
$60 million lawsuit alleges memory care understaffing, false billing
By
Lois A. Bowers
Jul 11, 2017
Forty-five senior living communities in North Carolina have defrauded the state and federal governments of more than $60 million by submitting claims for personal care services that, based on staffing...
Poor sleep, daytime napping could be signs of Alzheimer’s
By
Lois A. Bowers
Jan 10, 2019
Poor-quality sleep could be an early sign of Alzheimer’s disease in older adults, according to the findings of a new study, published Jan. 9 in the journal Science Translational Medicine.
Diabetes medications may offset severity of Alzheimer’s
By
John O'Connor
Nov 05, 2018
People with Alzheimer’s disease who were treated with diabetes drugs showed considerably fewer symptoms, Mount Sinai researchers have found.